Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Riya Rauthan"'
Autor:
Sundaram Acharya, Asgar Hussain Ansari, Prosad Kumar Das, Seiichi Hirano, Meghali Aich, Riya Rauthan, Sudipta Mahato, Savitri Maddileti, Sajal Sarkar, Manoj Kumar, Rhythm Phutela, Sneha Gulati, Abdul Rahman, Arushi Goel, C. Afzal, Deepanjan Paul, Trupti Agrawal, Vinay Kumar Pulimamidi, Subhadra Jalali, Hiroshi Nishimasu, Indumathi Mariappan, Osamu Nureki, Souvik Maiti, Debojyoti Chakraborty
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-23 (2024)
Abstract The clinical success of CRISPR therapies hinges on the safety and efficacy of Cas proteins. The Cas9 from Francisella novicida (FnCas9) is highly precise, with a negligible affinity for mismatched substrates, but its low cellular targeting e
Externí odkaz:
https://doaj.org/article/967b3513bca24917a4d3b9306cf6ba0f
Publikováno v:
Neuromethods ISBN: 9781071627198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0885660955c76b442535465b5472200
https://doi.org/10.1007/978-1-0716-2720-4_3
https://doi.org/10.1007/978-1-0716-2720-4_3
Autor:
Souvik Maiti, Riya Rauthan, Debojyoti Chakraborty, Mayank Bansal, Sundaram Acharya, Rhythm Phutela, Saumya Sharma
Publikováno v:
Ophthalmic Genetics. 42:365-374
Precision genome engineering, with targeted therapy towards patient-specific mutations is predicted to be the future of personalized medicine. Ophthalmology is in the frontiers of development of targeted therapy since the eye is an accessible organ a
Autor:
Osamu Nureki, Deepanjan Paul, Hiroshi Nishimasu, Vinay Kumar Pulimamidi, Manoj Kumar, Sneha Gulati, Rhythm Phutela, Sudipta Mahato, Riya Rauthan, Savitri Maddileti, Sundaram Acharya, Indumathi Mariappan, Souvik Maiti, Asgar Hussain Ansari, Seiichi Hirano, Debojyoti Chakraborty, Sajal Sarkar
The clinical success of CRISPR therapies is dependent on the safety and efficacy ofCas proteins. The Cas9 from Francisella novicida (FnCas9) has negligible affinity formismatched substrates enabling it to discriminate off-targets in DNA with very hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dfad937951f07b152fcbcfa597ffa99
https://doi.org/10.21203/rs.3.rs-990232/v2
https://doi.org/10.21203/rs.3.rs-990232/v2
Autor:
Souvik Maiti, Sunaina Singh, Harsha Lad, Manoj Kumar, Pradeep Kumar Patra, Riya Rauthan, Paras Sehgal, Sundaram Acharya, Dipanjali Sinha, Saumya Sharma, Rhythm Phutela, Poorti Kathpalia, Deepanjan Paul, Sajal Sarkar, Giriraj R. Chandak, Bala Pesala, Govind K. Makharia, Sneha Gulati, Khushboo Singhal, Namrata Sharma, Gyan Ranjan, Mohd Azhar, Rahul C. Bhoyar, Meghali Aich, Debojyoti Chakraborty, Asgar Hussain Ansari
Publikováno v:
Biosensors & Bioelectronics
Rapid detection of DNA/RNA pathogenic sequences or variants through point-of-care diagnostics is valuable for accelerated clinical prognosis, as witnessed during the recent COVID-19 outbreak. Traditional methods relying on qPCR or sequencing are toug
Autor:
Mohd Azhar, Sundaram Acharya, Khushboo Singhal, Souvik Maiti, Govind K. Makharia, Paras Sehgal, Namrata Sharma, Harsha Lad, Dipanjali Sinha, Giriraj R. Chandak, Poorti Kathpalia, Rhythm Phutela, Bala Pesala, Asgar Hussain Ansari, Meghali Aich, Pradeep Kumar Patra, Suchita Singh, Gyan Ranjan, Sachin Sharma, Rahul C. Bhoyar, Manoj Kumar, Deepanjan Paul, Riya Rauthan, Sneha Gulati, Debojyoti Chakraborty
Rapid detection of pathogenic sequences or variants in DNA and RNA through a point-of-care diagnostic approach is valuable for accelerated clinical prognosis as has been witnessed during the recent COVID-19 outbreak. Traditional methods relying on qP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87bdc7326c979958e3f2517997b4db1d
https://doi.org/10.1101/2020.09.13.20193581
https://doi.org/10.1101/2020.09.13.20193581
Autor:
Riya Rauthan, Arpit Mishra, Sundaram Acharya, Arjun Ray, Mohd Azhar, Shivani Jain, Dipanjali Sinha, Asgar Hussain Ansari, Suman L. Jain, Souvik Maiti, Meghali Aich, Deepanjan Paul, Debojyoti Chakraborty, Manoj Kumar, Sivaprakash Ramalingam, Saumya Sharma, Namrata Sharma
SUMMARYGenome editing using the CRISPR Cas9 system has been used to manipulate eukaryotic DNA and make precise heritable changes. Although the widely usedStreptococcus pyogenesCas9 (SpCas9) and its engineered variants have been efficiently harnessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72415f03680528d8e4d8d17707a44c24
https://europepmc.org/articles/PMC6800334/
https://europepmc.org/articles/PMC6800334/